This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.
Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Close

Theramex News

Our partners

Theramex is a leading global pharmaceutical company dedicated to women and their health, with a reputation for delivering impactful treatments to patients and driving value for our partners.

Learn more

News

8 March 2023

Theramex enters into an exclusive licensing agreement with Radius Health Inc, to commercialise ELADYNOS® in the European Economic Area, the United Kingdom, Australia and Brazil

Read more

17 June 2022

Theramex Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the treatment of symptoms of Uterine Fibroids

Read more

14 April 2022

Theramex UK Stock Update

Read more